Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Lakewood, CO
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Lakewood, CO
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Miami, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Orlando, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
mi
from
Minneapolis, MN
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects
A Phase 1, Open Label, Single‑Dose, Within Cohort Randomized, 2‑Way Crossover Study To Evaluate The Pharmacokinetics Of A Modified Release Formulation Of Pf‑06650833 Under Fasting And Fed Conditions In Healthy Adult Subjects
Status: Enrolling
Updated:  3/7/2016
New Haven Clinical Research Unit
mi
from
New Haven, CT
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects
A Phase 1, Open Label, Single‑Dose, Within Cohort Randomized, 2‑Way Crossover Study To Evaluate The Pharmacokinetics Of A Modified Release Formulation Of Pf‑06650833 Under Fasting And Fed Conditions In Healthy Adult Subjects
Status: Enrolling
Updated: 3/7/2016
New Haven Clinical Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Tempe, AZ
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Tempe, AZ
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Lincoln, NE
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Lincoln, NE
Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
A Phase 1, Randomized, Open-label, Parallel-design Study to Assess Absolute Bioavailability and Single-dose Pharmacokinetics Following Subcutaneous Administration of Sirukumab Delivered By A Pre-filled Syringe Fitted With UltraSafe Passive™ Delivery System or an Autoinjector in Healthy Male Subjects
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Stockbridge, GA
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Portland, OR
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
South Miami, FL
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
A Phase I Study of Topical Myristyl Nicotinate Cream on Human Skin in Healthy Volunteers
Status: Enrolling
Updated:  3/9/2016
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
A Phase I Study of Topical Myristyl Nicotinate Cream on Human Skin in Healthy Volunteers
Status: Enrolling
Updated: 3/9/2016
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Newport Beach, CA
A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Perception of Facial Expression in Subjects With and Without Crow's Feet Lines
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Saratoga Springs, NY
Perception of Facial Expression in Subjects With and Without Crow's Feet Lines
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
Audio-enhanced Analgesia in Healthy Subjects
Audio-enhanced Analgesia in Healthy Subjects
Status: Enrolling
Updated:  3/10/2016
Department of Psychiatry, Mass General Hospital
mi
from
Charlestown, MA
Audio-enhanced Analgesia in Healthy Subjects
Audio-enhanced Analgesia in Healthy Subjects
Status: Enrolling
Updated: 3/10/2016
Department of Psychiatry, Mass General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
Status: Enrolling
Updated:  3/11/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
Status: Enrolling
Updated: 3/11/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Vitamin D Supplementation in Older Women
Determination of RDA for Vitamin D in Caucasian and African American Women
Status: Enrolling
Updated:  3/11/2016
Creighton University Medical Center
mi
from
Omaha, NE
Vitamin D Supplementation in Older Women
Determination of RDA for Vitamin D in Caucasian and African American Women
Status: Enrolling
Updated: 3/11/2016
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy of Bitter Blockers on Taste Perception in Children and Adults
Efficacy of Bitter Taste Blockers on Flavor Acceptance in Pediatric Populations
Status: Enrolling
Updated:  3/14/2016
Monell Chemical Senses Center
mi
from
Philadelphia, PA
Efficacy of Bitter Blockers on Taste Perception in Children and Adults
Efficacy of Bitter Taste Blockers on Flavor Acceptance in Pediatric Populations
Status: Enrolling
Updated: 3/14/2016
Monell Chemical Senses Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Genetic Variability in Taste Perception
Genetic Variability in Taste Perception
Status: Enrolling
Updated:  3/14/2016
Monell Chemical Senses Center
mi
from
Philadelphia, PA
Genetic Variability in Taste Perception
Genetic Variability in Taste Perception
Status: Enrolling
Updated: 3/14/2016
Monell Chemical Senses Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
A Single Institution Feasibility Study to Assess Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Status: Enrolling
Updated:  3/15/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
A Single Institution Feasibility Study to Assess Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Status: Enrolling
Updated: 3/15/2016
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults - a Randomized Placebo-controlled Pilot Study
Status: Enrolling
Updated:  3/15/2016
Massachusetts General Hospital
mi
from
Boston, MA
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults - a Randomized Placebo-controlled Pilot Study
Status: Enrolling
Updated: 3/15/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Status: Enrolling
Updated:  3/15/2016
Massachusetts General Hospital
mi
from
Boston, MA
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Status: Enrolling
Updated: 3/15/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated:  3/16/2016
University of Michigan
mi
from
Ann Arbor, MI
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated: 3/16/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Single Ascending Dose Study of CD101 IV in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects
Status: Enrolling
Updated:  3/17/2016
Celerion
mi
from
Tempe, AZ
A Single Ascending Dose Study of CD101 IV in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects
Status: Enrolling
Updated: 3/17/2016
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Status: Enrolling
Updated:  3/17/2016
Site US00007
mi
from
Miami, FL
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Status: Enrolling
Updated: 3/17/2016
Site US00007
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
A Phase 1 Investigator-and-subject Blind, Randomized, Placebo Controlled, Parallel Study In Healthy Subjects To Evaluate The Pharmacodynamic Effects Of Single Oral Doses Of Pf-06648671 On Aβ Concentrations In Cerebrospinal Fluid Using Serial Sampling Methodology
Status: Enrolling
Updated:  3/21/2016
California Clinical Trials Medical Group
mi
from
Glendale, CA
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
A Phase 1 Investigator-and-subject Blind, Randomized, Placebo Controlled, Parallel Study In Healthy Subjects To Evaluate The Pharmacodynamic Effects Of Single Oral Doses Of Pf-06648671 On Aβ Concentrations In Cerebrospinal Fluid Using Serial Sampling Methodology
Status: Enrolling
Updated: 3/21/2016
California Clinical Trials Medical Group
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
A Phase 1 Investigator-and-subject Blind, Randomized, Placebo Controlled, Parallel Study In Healthy Subjects To Evaluate The Pharmacodynamic Effects Of Single Oral Doses Of Pf-06648671 On Aβ Concentrations In Cerebrospinal Fluid Using Serial Sampling Methodology
Status: Enrolling
Updated:  3/21/2016
Glendale Adventist Medical Center
mi
from
Glendale, CA
A Study to Evaluate the Pharmacodynamic Effects of Single Oral Doses of PF-06648671 on β-Amyloid (Aβ) Concentrations in Cerebrospinal Fluid (CSF)
A Phase 1 Investigator-and-subject Blind, Randomized, Placebo Controlled, Parallel Study In Healthy Subjects To Evaluate The Pharmacodynamic Effects Of Single Oral Doses Of Pf-06648671 On Aβ Concentrations In Cerebrospinal Fluid Using Serial Sampling Methodology
Status: Enrolling
Updated: 3/21/2016
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Multiple-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects
Status: Enrolling
Updated:  3/21/2016
Celerion
mi
from
Tempe, AZ
An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Multiple-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of CD101 Injection in Healthy Subjects
Status: Enrolling
Updated: 3/21/2016
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied Drug/Drug Interaction (DDI) Probe Compounds
Status: Enrolling
Updated:  3/21/2016
Quintiles, Inc.
mi
from
Overland Park, KA
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied Drug/Drug Interaction (DDI) Probe Compounds
Status: Enrolling
Updated: 3/21/2016
Quintiles, Inc.
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated:  3/21/2016
Clinical Research Facility
mi
from
Tempe, AZ
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated: 3/21/2016
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated:  3/21/2016
Clinical Research Facility
mi
from
Lincoln, NE
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated: 3/21/2016
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated:  3/21/2016
Clinical Research Facility
mi
from
Neptune, NJ
A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
A Phase 1, Randomized, Open-label, Parallel-design Study to Compare Single-dose Pharmacokinetics of Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status: Enrolling
Updated: 3/21/2016
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers
Status: Enrolling
Updated:  3/21/2016
Clinical Research Facility
mi
from
Austin, TX
Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers
Status: Enrolling
Updated: 3/21/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated:  3/22/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated: 3/22/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory
Effect of Direct Current Brain Polarization on Verbal Memory
Status: Enrolling
Updated:  3/23/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory
Effect of Direct Current Brain Polarization on Verbal Memory
Status: Enrolling
Updated: 3/23/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pharmacokinetics of Apremilast (CC-10004) in Healthy Elderly Subjects
An Open-Label, Single-Dose Study to Evaluate the Effects of Age and Sex on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated:  3/24/2016
Pra International
mi
from
Lenexa, KA
Pharmacokinetics of Apremilast (CC-10004) in Healthy Elderly Subjects
An Open-Label, Single-Dose Study to Evaluate the Effects of Age and Sex on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated: 3/24/2016
Pra International
mi
from
Lenexa, KA
Click here to add this to my saved trials
Pharmacokinetics of Apremilast (CC-10004) in Healthy Elderly Subjects
An Open-Label, Single-Dose Study to Evaluate the Effects of Age and Sex on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated:  3/24/2016
Clinical Development Services
mi
from
Dallas, TX
Pharmacokinetics of Apremilast (CC-10004) in Healthy Elderly Subjects
An Open-Label, Single-Dose Study to Evaluate the Effects of Age and Sex on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Subjects
Status: Enrolling
Updated: 3/24/2016
Clinical Development Services
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292
A Phase 1, Two-part Study to Investigate the Safety and Pharmacokinetics of AVL-292 Following Multiple Oral Doses and to Evaluate the Effect of Food on the Pharmacokinetics of AVL-292 Following a Single Oral Dose in Healthy Adult Subjects
Status: Enrolling
Updated:  3/24/2016
Covance Clinical Research Unit, Inc.
mi
from
Dallas, TX
Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Pharmacokinetics of AVL-292
A Phase 1, Two-part Study to Investigate the Safety and Pharmacokinetics of AVL-292 Following Multiple Oral Doses and to Evaluate the Effect of Food on the Pharmacokinetics of AVL-292 Following a Single Oral Dose in Healthy Adult Subjects
Status: Enrolling
Updated: 3/24/2016
Covance Clinical Research Unit, Inc.
mi
from
Dallas, TX
Click here to add this to my saved trials
Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects
A Phase 1 Receptor Occupancy Study Using Positron Emission Tomography to Investigate Novel Ligand [11C]TASP0410699 Alone and Following Single Oral Dose Administrations of TS-121 in Healthy Adult (Male) Subjects
Status: Enrolling
Updated:  3/25/2016
Yale University PET Center
mi
from
New Haven, CT
Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects
A Phase 1 Receptor Occupancy Study Using Positron Emission Tomography to Investigate Novel Ligand [11C]TASP0410699 Alone and Following Single Oral Dose Administrations of TS-121 in Healthy Adult (Male) Subjects
Status: Enrolling
Updated: 3/25/2016
Yale University PET Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
Status: Enrolling
Updated:  3/25/2016
University of Wisconsin
mi
from
Madison, WI
Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
Status: Enrolling
Updated: 3/25/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects
A Phase 1, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) Following Multiple Daily Doses in Healthy Male Subjects
Status: Enrolling
Updated:  3/25/2016
PPD Phase I Clinic
mi
from
Austin, TX
A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects
A Phase 1, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) Following Multiple Daily Doses in Healthy Male Subjects
Status: Enrolling
Updated: 3/25/2016
PPD Phase I Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
Radiolabeled Study of CC-122 in Healthy Subjects
A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C]-CC-122 in Healthy Male Subjects
Status: Enrolling
Updated:  3/25/2016
Covance Clinical Research Unit
mi
from
Madison, WI
Radiolabeled Study of CC-122 in Healthy Subjects
A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C]-CC-122 in Healthy Male Subjects
Status: Enrolling
Updated: 3/25/2016
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
Study of Bioavailability of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
Status: Enrolling
Updated:  3/28/2016
Mds Pharma Services
mi
from
Neptune, NJ
Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
Study of Bioavailability of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
Status: Enrolling
Updated: 3/28/2016
Mds Pharma Services
mi
from
Neptune, NJ
Click here to add this to my saved trials
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
A Phase 1, Open-Label, Two-Part, Fixed-Sequence Crossover Study to Evaluate the Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Male Subjects
Status: Enrolling
Updated:  3/29/2016
Covance Clinical Research Unit Dallas
mi
from
Dallas, TX
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
A Phase 1, Open-Label, Two-Part, Fixed-Sequence Crossover Study to Evaluate the Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Male Subjects
Status: Enrolling
Updated: 3/29/2016
Covance Clinical Research Unit Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  3/29/2016
PPD Development, LP
mi
from
Austin, TX
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
A Phase 1, Multicenter, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 3/29/2016
PPD Development, LP
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension
A Phase 1, Open-label, Randomized, Three-period, Two-way Crossover Study in Healthy Subjects to Evaluate the Bioavailability of a Test Lenalidomide Oral Suspension Relative to the Reference Capsule Formulation and to Assess the Effect of Food on the Bioavailability of Lenalidomide From the Oral Suspension
Status: Enrolling
Updated:  3/29/2016
Covance-Daytona Beach
mi
from
Daytona Beach, FL
Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension
A Phase 1, Open-label, Randomized, Three-period, Two-way Crossover Study in Healthy Subjects to Evaluate the Bioavailability of a Test Lenalidomide Oral Suspension Relative to the Reference Capsule Formulation and to Assess the Effect of Food on the Bioavailability of Lenalidomide From the Oral Suspension
Status: Enrolling
Updated: 3/29/2016
Covance-Daytona Beach
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated:  3/30/2016
Orange County Research Center
mi
from
Garden Grove, CA
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults
Status: Enrolling
Updated: 3/30/2016
Orange County Research Center
mi
from
Garden Grove, CA
Click here to add this to my saved trials